n-methylisoindigotin has been researched along with pyrrolidine dithiocarbamate in 1 studies
| Studies (n-methylisoindigotin) | Trials (n-methylisoindigotin) | Recent Studies (post-2010) (n-methylisoindigotin) | Studies (pyrrolidine dithiocarbamate) | Trials (pyrrolidine dithiocarbamate) | Recent Studies (post-2010) (pyrrolidine dithiocarbamate) |
|---|---|---|---|---|---|
| 34 | 0 | 11 | 1,097 | 1 | 342 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Liu, JJ; Ma, N; Mu, YL; Shentu, LM; Sun, Y; Wang, LY; Wang, Y; Zhang, GM | 1 |
1 other study(ies) available for n-methylisoindigotin and pyrrolidine dithiocarbamate
| Article | Year |
|---|---|
Inhibition of NF-κB and Wnt/β-catenin/GSK3β Signaling Pathways Ameliorates Cardiomyocyte Hypertrophy and Fibrosis in Streptozotocin (STZ)-induced Type 1 Diabetic Rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Lipid Metabolism; Male; Myocytes, Cardiac; NF-kappa B; Pyrrolidines; Rats; Streptozocin; Thiocarbamates; Wnt Signaling Pathway | 2020 |